Cargando…

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer

In patients with advanced bladder cancer receiving chemotherapy, early assessment of response can avoid unnecessary toxicity. The aim of this study was to assess the role of tumour markers in monitoring response. Serum levels of one or more of markers β human chorionic gonadotrophin (βhCG), carcinoe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, A M, Huddart, R A, Jay, G, Norman, A, Dearnaley, D P, Horwich, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363245/ https://www.ncbi.nlm.nih.gov/pubmed/10864203 http://dx.doi.org/10.1054/bjoc.2000.1147

Ejemplares similares

The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours
por: Cook, A M, et al.
Publicado: (2001)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2015)

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder
por: Hafeez, S, et al.
Publicado: (2016)

Germ cell tumour chemotherapy.
por: Horwich, A.
Publicado: (1989)

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours
por: Fosså, S D, et al.
Publicado: (1999)

Microsatellite instability in human testicular germ cell tumours.
por: Huddart, R. A., et al.
Publicado: (1995)

Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer
por: Parker, C C, et al.
Publicado: (2002)

Primary malignant mediastinal germ cell tumours: improved prognosis with platinum-based chemotherapy and surgery.
por: Childs, W. J., et al.
Publicado: (1993)

Fertility, gonadal and sexual function in survivors of testicular cancer
por: Huddart, R A, et al.
Publicado: (2005)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy in advanced solid tumours
por: Kosmas, C, et al.
Publicado: (2000)

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse
por: Hain, S F, et al.
Publicado: (2000)

Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy
por: Faithfull, S, et al.
Publicado: (2001)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy
por: Tuxen, M K, et al.
Publicado: (2001)

A Medical Research Council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma
por: Horwich, A, et al.
Publicado: (2000)

Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change.
por: Summersgill, B., et al.
Publicado: (1998)

Chemotherapy for unresectable and recurrent intramedullary glial tumours in children
por: Doireau, V, et al.
Publicado: (1999)

Advances in bladder cancer imaging
por: Hafeez, Shaista, et al.
Publicado: (2013)

Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults
por: Summersgill, B, et al.
Publicado: (2001)

p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer
por: Phillips, H A, et al.
Publicado: (2000)

Enhancement of chemotherapy and radiotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent
por: Patterson, L H, et al.
Publicado: (2000)

Enhancement of chemotherapy by manipulation of tumour pH
por: Raghunand, N, et al.
Publicado: (1999)

p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours
por: Le Frère-Belda, M A, et al.
Publicado: (2001)

Prevalence of hepatitis B virus marker positivity and evolution of hepatitis B virus profile, during chemotherapy, in patients with solid tumours
por: Alexopoulos, C G, et al.
Publicado: (1999)

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000)

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder
por: Edwards, J, et al.
Publicado: (2001)

Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy
por: Huddart, R A, et al.
Publicado: (2003)

The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy
por: Nicolini, A, et al.
Publicado: (1999)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Salvage therapy of germ cell tumours.
por: Horwich, A.
Publicado: (1995)

Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas
por: Ray-Coquard, I, et al.
Publicado: (2001)

Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma
por: Horwich, A, et al.
Publicado: (2014)

Recent advances in testicular germ cell tumours
por: Mele, Teresa, et al.
Publicado: (2021)

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer
por: Bottini, A, et al.
Publicado: (2001)

Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients
por: Pelosi, G, et al.
Publicado: (1999)

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
por: van der Heijden, Antoine G., et al.
Publicado: (2007)

Chemotherapy for advanced breast cancer: what influences oncologists' decision-making?
por: Grunfeld, E A, et al.
Publicado: (2001)

Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
por: Berney, D M, et al.
Publicado: (2001)

Long-term follow-up of residual masses after chemotherapy in patients with non-seminomatous germ cell tumours
por: Napier, M P, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_nmh57rk7qcbvms4g6kov269jpf